SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It
is not yet known which treatment regimen is more effective for rectal cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of
combination chemotherapy plus radiation therapy in treating patients who have rectal cancer
that has been surgically removed.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI) NCIC Clinical Trials Group North Central Cancer Treatment Group Radiation Therapy Oncology Group